Performance & RecoveryResearch Chemical

IGF-1 LR3

Also known as: Long R3 IGF-1

A long-acting form of insulin-like growth factor 1 studied for muscle growth and recovery.

Subcutaneous injection Intramuscular injection

Performance & Recovery

IGF-1 LR3

Subcutaneous injectionResearch Chemical

Research use only. Can cause hypoglycemia; theoretical cancer-promotion risk. Prohibited in sport. Not FDA-approved.

Overview

IGF-1 LR3 is a modified, longer-acting analog of insulin-like growth factor 1. The modifications extend its half-life and reduce binding to inhibitory proteins, making it a potent anabolic and recovery agent in research settings.

IGF-1 LR3 (Long R3 IGF-1) is a modified, longer-acting version of insulin-like growth factor 1, the primary anabolic messenger downstream of growth hormone. Two changes give it its potency: an added amino-acid chain that extends its half-life dramatically compared with native IGF-1, and a substitution that greatly reduces its binding to the IGF-binding proteins that normally hold IGF-1 in check. The result is a molecule that stays active far longer and signals more freely.

By activating the IGF-1 receptor, it drives muscle protein synthesis, satellite-cell proliferation, and even hyperplasia (new muscle-cell formation) in research settings. That potency cuts both ways: because it is closely related to insulin, it can cause hypoglycemia, and its strong pro-growth signaling raises theoretical concerns about promoting abnormal tissue growth. It is unapproved for human use and banned in sport.

Mechanism of Action

Activates the IGF-1 receptor, driving muscle protein synthesis, satellite-cell proliferation, and hyperplasia, with reduced binding to IGF-binding proteins for prolonged activity.

Use Cases

  • Muscle growth and recovery
  • Nutrient partitioning
  • Tissue repair

Research Summary

Potent anabolic effects are well documented in cell and animal research. Human use is unapproved; risks include hypoglycemia and concerns about promoting abnormal tissue growth.

Explain It Like I'm 5 Years Old

Growth hormone works mostly by telling your body to make another messenger called IGF-1, which is what actually builds muscle. IGF-1 LR3 is a supercharged version of that messenger that sticks around much longer and shouts its build-muscle message more loudly. Because it is a cousin of insulin, it can also drop your blood sugar, so it has to be handled carefully.

How the Gym Bros Are Using It

One of the more hardcore anabolics in the peptide space. Advanced bodybuilders run it for muscle growth, nutrient partitioning, and recovery, typically 20 to 50 mcg a day. The two things experienced users respect: it can crash your blood sugar (so people keep fast carbs handy), and its strong growth signaling makes tissue-growth safety a real consideration. Banned in sport, unapproved, and firmly advanced-user territory. Often stacked with MGF or GH secretagogues.

Typical Dosing

Research protocols: 20–50 mcg per day. Not a medical recommendation.

Administration

Subcutaneous injectionIntramuscular injection

Research Chemical

Research use only. Can cause hypoglycemia; theoretical cancer-promotion risk. Prohibited in sport. Not FDA-approved.

Related Peptides

Verified Sources for IGF-1 LR3

Browse all →